elrexfio
Generic: elranatamab-bcmm
Labeler: pfizer laboratories div pfizer incDrug Facts
Product Profile
Brand Name
elrexfio
Generic Name
elranatamab-bcmm
Labeler
pfizer laboratories div pfizer inc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
elranatamab 44 mg/1.1mL
Manufacturer
Identifiers & Regulatory
Product NDC
0069-2522
Product ID
0069-2522_0080902a-fc95-4612-8df2-1fd00bbaed23
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
BLA
Application Number
BLA761345
Listing Expiration
2027-12-31
Marketing Start
2023-08-15
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
00692522
Hyphenated Format
0069-2522
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
elrexfio (source: ndc)
Generic Name
elranatamab-bcmm (source: ndc)
Application Number
BLA761345 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 44 mg/1.1mL
Packaging
- 1 VIAL, SINGLE-DOSE in 1 CARTON (0069-2522-02) / 1.1 mL in 1 VIAL, SINGLE-DOSE (0069-2522-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "0080902a-fc95-4612-8df2-1fd00bbaed23", "openfda": {"unii": ["L0HR9A577V"], "rxcui": ["2644885", "2644891", "2644893", "2644894"], "spl_set_id": ["f6fea598-ff58-4a20-b5e8-8a51f37d8beb"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0069-2522-02) / 1.1 mL in 1 VIAL, SINGLE-DOSE (0069-2522-01)", "package_ndc": "0069-2522-02", "marketing_start_date": "20230815"}], "brand_name": "Elrexfio", "product_id": "0069-2522_0080902a-fc95-4612-8df2-1fd00bbaed23", "dosage_form": "INJECTION, SOLUTION", "product_ndc": "0069-2522", "generic_name": "elranatamab-bcmm", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Elrexfio", "active_ingredients": [{"name": "ELRANATAMAB", "strength": "44 mg/1.1mL"}], "application_number": "BLA761345", "marketing_category": "BLA", "marketing_start_date": "20230815", "listing_expiration_date": "20271231"}